TY - JOUR
T1 - Spirometry guidelines influence lung function results in a longitudinal study of young adults
AU - Smith, Lewis J.
AU - Arynchyn, Alexander
AU - Kalhan, Ravi
AU - Williams, O. Dale
AU - Jensen, Robert
AU - Crapo, Robert
AU - Jacobs, David R.
N1 - Funding Information:
Supported by National Heart, Lung, and Blood Institute contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050 (CARDIA field centers), N01-HC-95095 (CARDIA Coordinating Center), and N01-HC045134 Reading Center (CARDIA Pulmonary Reading Center).
PY - 2010/6
Y1 - 2010/6
N2 - Rationale: End of test criteria can influence spirometry results. Epidemiology studies initiated before adoption of the 1987 American Thoracic Society (ATS) guidelines typically used a 1 or 2 s plateau on the volume-time curve, not a minimum test duration of 6 s, to terminate a test. Objectives: To determine the effect of changing guidelines on FEV1, FVC and FEV1/FVC during a longitudinal study of young adults. Methods: Spirometry was performed on participants in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Values obtained at entry and 2, 5 and 10 years later using accepted procedures were re-evaluated using the 2005 ATS-ERS guidelines, which were in effect for the year 20 exam. Generalized estimating equations were used to adjust tests with short exhalations that were acceptable by then current end of test criteria. Results: The percentage of participants at years 0, 2, 5, and 10 with exhalations less than 6 s but with an acceptable plateau was 33%, 29%, 9%, and 2%, respectively. Exhalations less than 6 s occurred more frequently in younger and female participants, and were associated with lower FVC and higher FEV1/FVC. For short exhalations the adjusted FVC was 47 ml and 110 ml higher than the measured FVC when 6 and 8 s exhalation times were used. Conclusions: In longitudinal studies of young adults, changing end of test criteria may affect lung function, especially among younger and female participants. Determining adjusted values for tests with short exhalations may better represent the lung health of participants.
AB - Rationale: End of test criteria can influence spirometry results. Epidemiology studies initiated before adoption of the 1987 American Thoracic Society (ATS) guidelines typically used a 1 or 2 s plateau on the volume-time curve, not a minimum test duration of 6 s, to terminate a test. Objectives: To determine the effect of changing guidelines on FEV1, FVC and FEV1/FVC during a longitudinal study of young adults. Methods: Spirometry was performed on participants in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Values obtained at entry and 2, 5 and 10 years later using accepted procedures were re-evaluated using the 2005 ATS-ERS guidelines, which were in effect for the year 20 exam. Generalized estimating equations were used to adjust tests with short exhalations that were acceptable by then current end of test criteria. Results: The percentage of participants at years 0, 2, 5, and 10 with exhalations less than 6 s but with an acceptable plateau was 33%, 29%, 9%, and 2%, respectively. Exhalations less than 6 s occurred more frequently in younger and female participants, and were associated with lower FVC and higher FEV1/FVC. For short exhalations the adjusted FVC was 47 ml and 110 ml higher than the measured FVC when 6 and 8 s exhalation times were used. Conclusions: In longitudinal studies of young adults, changing end of test criteria may affect lung function, especially among younger and female participants. Determining adjusted values for tests with short exhalations may better represent the lung health of participants.
KW - CARDIA
KW - Forced expiratory time
KW - Forced expiratory volume in 1 s (FEV)
KW - Forced vital capacity (FVC)
KW - Pulmonary function testing
KW - Spirometry
UR - http://www.scopus.com/inward/record.url?scp=77952287622&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952287622&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2009.12.006
DO - 10.1016/j.rmed.2009.12.006
M3 - Article
C2 - 20047823
AN - SCOPUS:77952287622
SN - 0954-6111
VL - 104
SP - 858
EP - 864
JO - Respiratory Medicine
JF - Respiratory Medicine
IS - 6
ER -